Abril L - Search Results

1

The Relative Efficacy of Seven Skeletal Muscle Relaxants. An Analysis of Data From Randomized Studies.

Abril L, Zamora C, Cordero M, Williams AR, Friedman BW. Abril L, et al. J Emerg Med. 2022 Apr;62(4):455-461. doi: 10.1016/j.jemermed.2021.09.025. Epub 2022 Jan 20. J Emerg Med. 2022. PMID: 35067395

2

Predicting the Transition to Chronic Pain 6 Months After an Emergency Department Visit for Acute Pain: A Prospective Cohort Study.

Friedman BW, Abril L, Naeem F, Irizarry E, Chertoff A, McGregor M, Bijur PE, Gallagher EJ. Friedman BW, et al. Among authors: abril l. J Emerg Med. 2020 Dec;59(6):805-811. doi: 10.1016/j.jemermed.2020.07.016. Epub 2020 Sep 9. J Emerg Med. 2020. PMID: 32919839 Free PMC article.

3

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience.

Huguet M, Boigues M, Sorigué M, Blanco J, Quirant B, Ferrà C; study group; Annex. Members of the study group. Huguet M, et al. Med Clin (Barc). 2024 Apr 12;162(7):313-320. doi: 10.1016/j.medcli.2023.10.016. Epub 2023 Nov 23. Med Clin (Barc). 2024. PMID: 38000941 English, Spanish.

4

First-line treatment of multiple myeloma in both transplant and non-transplant candidates.

Oriol A, Abril L, Ibarra G. Oriol A, et al. Among authors: abril l. Expert Rev Anticancer Ther. 2023 Jul;23(7):685-698. doi: 10.1080/14737140.2023.2213891. Epub 2023 May 16. Expert Rev Anticancer Ther. 2023. PMID: 37194283 Review.

5

Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era.

Del Río-Garma J, Bobillo S, de la Rubia J, Pascual C, García-Candel F, García-Gala JM, Gonzalez R, Abril L, Vidan J, Gomez MJ, Peña F, Arbona C, Martín-Sanchez J, Moreno G, Romón I, Viejo A, Oliva A, Linares M, Salinas R, Pérez S, Garcia-Erce JA, Pereira A; “Registro Español de la Púrpura Trombocitopénica Trombótica (REPTT)”, and the “Grupo Español de Aféresis (GEA)”. Del Río-Garma J, et al. Among authors: abril l. Ann Hematol. 2022 Jan;101(1):59-67. doi: 10.1007/s00277-021-04685-8. Epub 2021 Oct 12. Ann Hematol. 2022. PMID: 34642787

6

Attitudes towards chiropractic: a repeated cross-sectional survey of Canadian family physicians.

Busse JW, Pallapothu S, Vinh B, Lee V, Abril L, Canga A, Riva JJ, Viggiani D, Dilauro M, Harvey MP, Pagé I, Bhela AK, Sandhu S, Makanjuola O, Hassan MT, Moore A, Gauthier CA, Price DJ. Busse JW, et al. Among authors: abril l. BMC Fam Pract. 2021 Sep 15;22(1):188. doi: 10.1186/s12875-021-01535-4. BMC Fam Pract. 2021. PMID: 34525953 Free PMC article.

7

The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma.

Oriol A, Abril L, Torrent A, Ibarra G, Ribera JM. Oriol A, et al. Among authors: abril l. Ther Adv Hematol. 2021 May 31;12:20406207211019622. doi: 10.1177/20406207211019622. eCollection 2021. Ther Adv Hematol. 2021. PMID: 34104374 Free PMC article. Review.

8

Dose intensity and treatment duration of bortezomib in transplant-ineligible newly diagnosed multiple myeloma.

Ibarra G, Peña M, Abril L, Senín A, Maluquer C, Clapés V, Baca C, Bustamante G, Sureda A, Oriol A. Ibarra G, et al. Among authors: abril l. Eur J Haematol. 2021 Aug;107(2):246-254. doi: 10.1111/ejh.13643. Epub 2021 May 26. Eur J Haematol. 2021. PMID: 33934417

9

Limited treatment options in refractory multiple myeloma: promising therapeutic developments.

Oriol A, Abril L, Ibarra G, Senin A. Oriol A, et al. Among authors: abril l. Expert Rev Anticancer Ther. 2020 Jan;20(1):31-44. doi: 10.1080/14737140.2020.1708721. Epub 2020 Jan 3. Expert Rev Anticancer Ther. 2020. PMID: 31865804 Review.

10

Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?

Gassiot S, González Y, Morgades M, Motlló C, Clapés V, Maluquer C, Ibarra G, Abril L, Ribera JM, Oriol A. Gassiot S, et al. Among authors: abril l. Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):585-592.e1. doi: 10.1016/j.clml.2019.05.020. Epub 2019 Jun 5. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31255588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page